WuXi AppTec (WuXi), a supplier of R&D services to the pharmaceutical, biotechnology, and medical device industries, has selected Instem, a provider of IT solutions to the global early development healthcare market, for Provantis Portal Remote Study Monitoring solution.
Launched in 2012, the Provantis Portal allows WuXi’s toxicology clients to log into a secure web portal using any standard browser to view data from their on-going studies on-demand.
This allows WuXi clients, mainly global organizations, to oversee their studies remotely and communicate more effectively.
Earlier in 2009, WuXi selected Instem’s integrated Provantis preclinical solution suite to automate study processes at their newly constructed 314,000ft² toxicology facility in Suzhou.
WuXi Preclinical Services vice president said, "WuXi’s mission is to create a broad, integrated platform of R&D services that will allow anyone and any company to develop new medicines efficiently and cost effectively."
Instem delivers compelling solutions for data collection, management and analysis across the R&D continuum. Its portfolio of software solutions increases client productivity by automating study-related processes while offering the ability to generate new knowledge through the extraction and harmonization of actionable scientific information.